PFM Therapeutics Fund, L.P.
PFM Therapeutics Fund, L.P. is a hedge fund based in San Francisco, California. According to its most recent Form D, filed May 2, 2019, the fund has sold $158,601,370 of interests to 36 investors since its first sale in Jul 2014. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Partner Fund Management, L.p; Partner Asset Management, LLC; Christopher James.
Performance
No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $158,601,370Cumulative sales reported on Form D
- Investors
- 36
- First sale
- Jul 1, 2014
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Partner Fund Management, L.p; Partner Asset Management, LLC; Christopher James
- Latest Form D
- May 2, 2019
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| May 2, 2019 | Form D/A (amendment) | $158,601,370 | 36 | SEC.gov ↗ |
| Nov 2, 2018 | Form D/A (amendment) | $81,082,200 | 30 | SEC.gov ↗ |
| May 4, 2018 | Form D/A (amendment) | $54,929,490 | 22 | SEC.gov ↗ |
| Jul 19, 2017 | Form D/A (amendment) | $54,929,490 | 22 | SEC.gov ↗ |
| May 5, 2017 | Form D/A (amendment) | $54,929,490 | 22 | SEC.gov ↗ |
| May 4, 2016 | Form D/A (amendment) | $53,728,003 | 21 | SEC.gov ↗ |
| May 6, 2015 | Form D/A (amendment) | $34,901,381 | 15 | SEC.gov ↗ |
| Jun 13, 2014 | Form D | $0 | 0 | SEC.gov ↗ |
8 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jun 13, 2014. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Related vehicles with the same name (2)
| Vehicle | Total raised | Investors | Latest Form D |
|---|---|---|---|
| PFM Therapeutics Offshore Fund, Ltd. | $271,637,702 | 36 | May 2, 2019 |
| PFM Therapeutics Fund, L.P. (this page) | $158,601,370 | 36 | May 2, 2019 |
Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 2 filings share this fund's name apart from such vehicle words or a series letter, which usually means they are versions of one fund. Grouped by AltMountain from the names on the filings alone, so the list may be incomplete or include a separate fund with a near-identical name; amounts are each vehicle's own filing and should not be added together, because a feeder's money can also be counted in its master fund. Source: SEC Form D filings.
Questions about PFM Therapeutics Fund, L.P.
What is the minimum investment for PFM Therapeutics Fund, L.P.?
PFM Therapeutics Fund, L.P.'s latest Form D, filed May 2, 2019, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in PFM Therapeutics Fund, L.P.?
PFM Therapeutics Fund, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has PFM Therapeutics Fund, L.P. raised?
PFM Therapeutics Fund, L.P. reports $158,601,370 sold from 36 investors on its Form D filed May 2, 2019. This is cumulative sales since the offering began, not current assets or performance.
Where is PFM Therapeutics Fund, L.P. based?
PFM Therapeutics Fund, L.P. is based in San Francisco, California.
When did PFM Therapeutics Fund, L.P. launch?
PFM Therapeutics Fund, L.P. reports its first sale in Jul 2014.
Size compared with every hedge fund
Raised more than 74% of the 1,049 hedge funds based in California, and more than 65% of all 10,160 that report sales.